Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy

OBJECTIVES: Patients with systemic lupus erythematosus (SLE) are at higher risk of haematological malignancies (HMs) than the general population. Most reports have focused on HM diagnosed after SLE, and have excluded concurrent and preceding diagnoses. Information on response to therapy is also limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Knight, Jason S, Blayney, Douglas W, Somers, Emily C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Co-Morbidities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246917/
https://www.ncbi.nlm.nih.gov/pubmed/25452880
http://dx.doi.org/10.1136/lupus-2014-000051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246917/
https://www.ncbi.nlm.nih.gov/pubmed/25452880
http://dx.doi.org/10.1136/lupus-2014-000051

Ejemplares similares